161 related articles for article (PubMed ID: 22160855)
1. Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions.
Favaedi R; Shahhoseini M; Akhoond MR
Mol Cell Biochem; 2012 Apr; 363(1-2):129-34. PubMed ID: 22160855
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic analysis of human embryonic carcinoma cells during retinoic acid-induced neural differentiation.
Shahhoseini M; Taei A; Mehrjardi NZ; Salekdeh GH; Baharvand H
Biochem Cell Biol; 2010 Jun; 88(3):527-38. PubMed ID: 20555394
[TBL] [Abstract][Full Text] [Related]
4. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
5. Histone Modifications on the Promoters of Human OCT4 and NANOG Genes at the Onset of Neural Differentiation of NT2/D1 Cells.
Topalovic V; Schwirtlich M; Stevanovic M; Mojsin M
Biochemistry (Mosc); 2017 Jun; 82(6):715-722. PubMed ID: 28601081
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
8. A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4.
Smith JA; Ndoye AM; Geary K; Lisanti MP; Igoucheva O; Daniel R
Aging Cell; 2010 Aug; 9(4):580-91. PubMed ID: 20477760
[TBL] [Abstract][Full Text] [Related]
9. Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140.
Wu CY; Feng X; Wei LN
Nucleic Acids Res; 2014 Apr; 42(7):4306-17. PubMed ID: 24489122
[TBL] [Abstract][Full Text] [Related]
10. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
11. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis.
Feldman N; Gerson A; Fang J; Li E; Zhang Y; Shinkai Y; Cedar H; Bergman Y
Nat Cell Biol; 2006 Feb; 8(2):188-94. PubMed ID: 16415856
[TBL] [Abstract][Full Text] [Related]
12. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid.
Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210
[TBL] [Abstract][Full Text] [Related]
13. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid.
Lee ER; Murdoch FE; Fritsch MK
Stem Cells; 2007 Sep; 25(9):2191-9. PubMed ID: 17525233
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic role of CCAAT box-binding transcription factor NF-Y on ID gene family in human embryonic carcinoma cells.
Moeinvaziri F; Shahhoseini M
IUBMB Life; 2015 Nov; 67(11):880-7. PubMed ID: 26509926
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.
Balmer NV; Weng MK; Zimmer B; Ivanova VN; Chambers SM; Nikolaeva E; Jagtap S; Sachinidis A; Hescheler J; Waldmann T; Leist M
Hum Mol Genet; 2012 Sep; 21(18):4104-14. PubMed ID: 22723015
[TBL] [Abstract][Full Text] [Related]
16. Regulation of OCT4 gene expression by liver receptor homolog-1 in human embryonic carcinoma cells.
Sung B; Do HJ; Park SW; Huh SH; Oh JH; Chung HJ; Kang MJ; Kim JH; Kim NH; Kim JH
Biochem Biophys Res Commun; 2012 Oct; 427(2):315-20. PubMed ID: 23000165
[TBL] [Abstract][Full Text] [Related]
17. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.
AlAbdi L; Saha D; He M; Dar MS; Utturkar SM; Sudyanti PA; McCune S; Spears BH; Breedlove JA; Lanman NA; Gowher H
Cell Rep; 2020 Feb; 30(5):1478-1490.e6. PubMed ID: 32023463
[TBL] [Abstract][Full Text] [Related]
18. NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.
Park Y; Lee JM; Hwang MY; Son GH; Geum D
Mol Cells; 2013 Jan; 35(1):61-9. PubMed ID: 23212346
[TBL] [Abstract][Full Text] [Related]
19. Comparative SRY incorporation on the regulatory regions of pluripotency/differentiation genes in human embryonic carcinoma cells after retinoic acid induction.
Kakhki SA; Shahhoseini M; Salekdeh GH
Mol Cell Biochem; 2013 Apr; 376(1-2):145-50. PubMed ID: 23361361
[TBL] [Abstract][Full Text] [Related]
20. Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth.
Li Q; O'Malley ME; Bartlett DL; Guo ZS
Mol Cancer; 2011 May; 10():63. PubMed ID: 21609483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
